Latin America Ophthalmic Drugs Market Size & Outlook

The ophthalmic drugs market in Latin America is expected to reach a projected revenue of US$ 3,091.7 million by 2030. A compound annual growth rate of 8.6% is expected of Latin America ophthalmic drugs market from 2024 to 2030.

Revenue, 2023 (US$M)
$1,731.4
Forecast, 2030 (US$M)
$3,091.7
CAGR, 2024 - 2030
8.6%
Report Coverage
Latin America

Latin America ophthalmic drugs market highlights

  • The Latin America ophthalmic drugs market generated a revenue of USD 1,731.4 million in 2023.
  • The market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
  • In terms of segment, anti-vegf agents was the largest revenue generating drug class in 2023.
  • Anti-VEGF agents is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.

Latin America data book summary

Market revenue in 2023USD 1,731.4 million
Market revenue in 2030USD 3,091.7 million
Growth rate8.6% (CAGR from 2023 to 2030)
Largest segmentAnti-vegf agents
Fastest growing segmentAnti-VEGF agents
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAnti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma
Key market players worldwidePfizer Inc, Alcon Inc, Novartis AG ADR, Bausch Health Companies Inc, Merck & Co Inc, Regeneron Pharmaceuticals Inc, AbbVie Inc, Bayer AG, Genentech, Nicox SA Share from reverse split, Coherus BioSciences Inc

Other key industry trends

  • In terms of revenue, Latin America region accounted for 4.6% of the global ophthalmic drugs market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 16,136.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Ophthalmic Drugs Market Scope

Ophthalmic drugs market segmentation & scope
Anti-Allergy
Anti-VEGF agents
Non-steroidal drugs
Steroids
Anti-glaucoma
Gene & Cell Therapy
Others
Dry eye
Allergies
Glaucoma
Infection
Macular Degeneration
Diabetic Retinopathy
Others
Uveitis
Others
Topical
Subconjunctival
Intravitreal
Retrobulbar
Intracameral
Sytemic
Gels
Eye solutions & suspensions
Capsules & Tablets
Eye drops
Ointments

Ophthalmic Drugs Market Companies

Name Profile # Employees HQ Website

Latin America ophthalmic drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.


Anti-vegf agents was the largest segment with a revenue share of 32.83% in 2023. Horizon Databook has segmented the Latin America ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma covering the revenue growth of each sub-segment from 2018 to 2030.


  • Latin America Ophthalmic Drugs Drug class Outlook (Revenue, USD Million, 2018-2030)
    • Anti-Allergy
    • Anti-VEGF agents
    • Anti-inflammatory
      • Non-steroidal drugs
      • Steroids
    • Anti-glaucoma
    • Gene & Cell Therapy
    • Others
  • Latin America Ophthalmic Drugs Disease Outlook (Revenue, USD Million, 2018-2030)
    • Dry eye
    • Allergies
    • Glaucoma
    • Infection
    • Retinal Disorders
      • Macular Degeneration
      • Diabetic Retinopathy
      • Others
    • Uveitis
    • Others
  • Latin America Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Topical
    • Local Ocular
      • Subconjunctival
      • Intravitreal
      • Retrobulbar
      • Intracameral
    • Sytemic
  • Latin America Ophthalmic Drugs Dosage Type Outlook (Revenue, USD Million, 2018-2030)
    • Gels
    • Eye solutions & suspensions
    • Capsules & Tablets
    • Eye drops
    • Ointments

Reasons to subscribe to Latin America ophthalmic drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America ophthalmic drugs market databook

  • Our clientele includes a mix of ophthalmic drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America ophthalmic drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Latin America ophthalmic drugs market size, by country, 2018-2030 (US$M)

Latin America Ophthalmic Drugs Market Outlook Share, 2023 & 2030 (US$M)

Latin America ophthalmic drugs market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more